Search Within

Susan E Prockop

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (23)
Groups
  1. Biostatistics Service (50)
  2. Department of Medicine (50)
  3. Epidemiology and Biostatistics (50)
  4. Pediatrics, Department of (50)
  5. Stem Cell Transplantation and Cellular Therapy Service (50)
  6. Tow Center for Developmental Oncology (TCDO) (43)

More Groups

People
  1. Nancy Kernan (39)
  2. Richard O'Reilly (38)
  3. Farid Boulad (30)
  4. Andromachi Scaradavou (27)
  5. Miguel-Angel Perales (22)
  6. Audrey Mauguen (21)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (4)
  4. 2021 (2)
  5. 2020 (12)
  6. 2019 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (19)
  2. Blood (11)
  3. Bone Marrow Transplantation (7)
  4. Blood Advances (3)
  5. Cytotherapy (2)
  6. Journal of Clinical Investigation (2)

More Publications

Publishers
  1. Elsevier Inc. (21)
  2. American Society of Hematology (14)
  3. Nature Publishing Group (8)
  4. American Society for Clinical Investigation (2)
  5. Elsevier Science Ltd. (2)
  6. Wiley Periodicals, Inc (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation
    Journal Article

    Harnicar, S.; Ponce, D. M.; Hilden, P.; Zheng, J.; Devlin, S. M.; Lubin, M.; Pozotrigo, M.; Mathew, S.; Adel, N.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
    Journal Article

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S. M.; Lubin, M.; Giralt, S.; Goldberg, J. D.; Hanash, A.; Hsu, K.; Jenq, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing is safe from the standpoint of engraftment and reduces severe acute graft-versus-host disease (aGVHD) after double-unit cord blood transplantation (DCBT): An analysis of 173 patients
    Meeting Abstract

    Ponce, D. M.; Harnicar, S.; Hilden, P.; Devlin, S.; Evans, K.; Lubin, M.; Kernan, N.; Prockop, S. E.; Scaradavou, A.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Safe G-CSF mobilization of thalassemia patient CD34+cells and effective globin gene transduction for therapeutic infusion
    Meeting Abstract

    Boulad, F.; Wang, X. Y.; Taylor, C.; Qu, J. R.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Molecular Therapy (2013)

    Fulltext@MSK | Save